Aminoglutethimide is primarily used for the treatment of advanced breast cancer (especially in postmenopausal women with estrogen receptor-positive tumors), ovarian cancer, prostate cancer, and adrenocortical carcinoma. It is also used in the management of hypercortisolism (Cushing's syndrome) and Cushingoid syndromes caused by adrenal tumors.